地点:Grand Hyatt Shanghai
主办单位: IBC Asia (S) Pte Ltd
会议简介
According to Business Insights, an estimated $25bn worth of biologics will lose patent protection by 2016, creating a significant market opportunity for biosimilars. However, the reality is that biosimilar development is a risk-fraught activity that demands significant resources in R&D, manufacturing expertise, regulatory know-how, clinical-trial capabilities, and a high level of financial investment.
Biosimilar development is riddled with complexities, ranging from regulatory, to manufacturing to marketing, and is one of the most expensive propositions in the pharmaceutical industry. It is estimated that it costs between US$100-200 million to bring a biosimilar product to market. With so much at stake, biosimilars represent not only substantial growth but equally risk..
IBC’s 2nd Annual Biosimilars Asia 2011 Summit is the ONLY conference in Asia catering to this region’s specific queries. With unprecedented insights from leading innovators and biosimilar companies, you will network and learn how to strategically position your company to maximize your ROI. Biosimilars Asia 2011 is attended by key stakeholders in the region and beyond, enabling you to make informed strategic decisions.
5 Reasons To Attend |
|
Industry Gurus / Speakers |
Biocon, Pfizer, Genentech, Roche, Teva, Hospira, Sandoz, Momenta, Intas, Dr Reddy’s, Shenzhen Main Luck Pharmaceuticals |
Past Attendees Include |
Vice President, ASTRAZENECA INNOVATION CENTER (China) Senior Director, GENENTECH INC, (USA) Managing Director, BECTON DICKINSON CO (BD BIOSCIENCES) (Singapore) Managing Director, ASAHI GLASS CO LTD (Japan) Deputy General Manager, SINOPHARM (China) Head, Biotech Research, USV LTD (India) General Manager, JCR PHARMACEUTICALS CO LTD (Japan) Vice President, R&D/Business Development, MAIN LUCK PHARMACEUTICALS INC (China) Senior Research Associate, HANWHA CHEMICAL (South Korea) Vice President, BOEHRINGER INGELHEIM GMBH (Germany) General Manager, GLAXOSMITHKLINE (CHINA) INVESTMENT CO LTD (China) IP Director, HOSPIRA (AUSTRALIA) President, MYCENAX BIOTECH INC (Taiwan) Senior Director, MERCK & CO INC (USA) Associate Director, DR REDDY''''''''S LABORATORIES LTD (India) Chairman, SHENZHEN SCIPROGEN BIO-PHARMACEUTICAL CO LTD (SCIPROGEN) (China)COO, SHANGHAI CELGEN BIOPHARMACEUTICALS (China) Chief Representative, TTY BIOPHARM CO LTD (Taiwan)COO, 3SBIO (China) Project Director, JIANGSU CHIA TAI TIANQING PHARMACEUTICAL CO LTD (China)Associate Director, PFIZER INVESTMENT CO LTD (China) General Manager, NIPPON KAYAKU CO LTD (Japan) President, HENLIUS BIOPHARMACEUTICALS INC & SHANGHAI HENLIUS BIOTECH (USA) Vice President, RANBAXY (USA) |
Registration |
FEES per delegate | Early Bird Rate Register & Pay before 11 March 2011 | Special Rate Register & Pay before 15 April 2011 | Normal Rate Register & Pay after 15 April 2011 | Group Rate Group of 3 or more |
? | US$ / CNY | US$ / CNY | US$ / CNY | US$ / CNY |
4 day package (Conf + Pre & Post Workshops) | 2,495 / 16,600 | 2,695 / 17,950 | 2,895 / 19,500 | 2,175 / 14,650 |
3.5 day package (Conf + Workshop C & A or B ) | 2,295 / | 2,495 / 16,600 | 2,695 / 17,950 | 2,025 / 13,500 |
3 day package (Conf + Workshop A & B or C) | 1,995 / 13,500 | 2,195 / 14,600 | 2,395 / 15,950 | 1,795 / |
2.5 day package (Conf + Workshop A or B) | 1,795 / 12,000 | 1,995 / 13,500 | 2,195 / 14,600 | 1,695 / 10,950 |
2 day package (Conf only) | 1,495 / 9,950 | 1,695 / 11,300 | 1,895 / 12,600 | 1,495 / 9,950 |
PAYMENT TERMS
Payment must be received 10 business days prior to the event. To take advantage of discounts with an expiry cut-off date, registration and payment must be received by the cut off date.
Payments by Singapore Dollars (S$)
- Payments by S$ bank draft or cheque should be made in favour of “IBC Asia (S) Pte Ltd” payable in Singapore.
- Payment by telegraphic transfer in S$ must be made to:
IBC Asia (S) Pte Ltd
A/C No.: 147-059513-001 (SGD)
The Hongkong and Shanghai Banking Corporation Limited
21 Collyer Quay, HSBC Building, Singapore 049320
Bank Swift Code: HSBCSGSG
Bank Code: 7232 - Payment by Credit Card (AMEX, VISA or MASTERCARD). Please provide your Card Number, Name of Cardholder, Expiry Date and your Signature and send it by fax to +65 6508 2407.
Payments by RMB (CNY)
- Payment by telegraphic transfer in CNY must be made to:
A/C Name:
A/C No.: 720-031103-001
Beneficiary Bank:
Bank Address: No. 1000 Lujiazui Rind Road,
Pudong, Shanghai 200120, P.R. China
Bank Swift Code: HSBCCNSH
CANCELLATIONS SUBSTITUTION
Should you be unable to attend, a substitute delegate is welcome at no extra charge. Cancellations must be received in writing at least 10 business days before the start of the event, to receive a refund less 10% processing fee per registration. The company regrets that no refund will be made available for cancellation notifications received less than 10 business days before the event.
IMPORTANT NOTE:
Please quote the name of the delegate, event title and invoice number on the advice when remitting payment. Bank charges are to be deducted from participating organisations own accounts. Please fax your payment details (copy of remittance advice, cheque or draft to +65 6508 2407.
Attendance will only be permitted upon receipt of full payment. Participants wishing to register at the door are responsible to ensure all details are as published. IBC Asia will not be responsible for any event re-scheduled or cancelled.
DATA PROTECTION
The personal information entered during your registration/order, or provided by you, will be held on a database and may be shared with companies in the Informa Group in the UK and internationally. Sometimes your details may be obtained from or shared with external companies for marketing purposes. If you do not wish your details to be used for this purpose, please contact Winnie Seah (Database) on winnie.seah@ibcasia.com.sg Tel: +65 6508 2468 or Fax: +65 6508 2408.
联系方式
电话:+65 650 82401